MILLER RICHARD A MD (President and CEO) purchased 0.6% of their position (6.93K shares) of CORVUS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $83.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/20/2026ACC: 0001610717-26-000160
DirectorOfficer· President and CEO
Since Dec 2018
+6.93K
Net shares
Net buyer
$83.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
6.93K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+5K
Price / share
$12.05
Trade value
$60.25K
% of position
0.4%
5/18/2026
1.19M→1.19M
Common Stock
Indirect
Shares
+1.93K
Price / share
$12.01
Trade value
$23.20K
% of position
0.2%
5/18/2026
1.19M→1.20M
Total
Net shares
+6.93K
Net value
$83.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/18/2026 | P · Purchase | +5K | $12.05 | $60.25K | 0.4% | 1.19M | 1.19M |
| Common Stock Indirect | 5/18/2026 | P · Purchase | +1.93K | $12.01 | $23.20K | 0.2% | 1.19M | 1.20M |
| Total | +6.93K | $83.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.14M
Total
1.14M direct1.14M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.14M | Direct |
| Total | 1.14M | 1.14M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported